CA2629337A1 - Emploi d'ingenanes substitues par des groupements angeloyle en combinaison avec d'autres agents dans le traitement du cancer - Google Patents
Emploi d'ingenanes substitues par des groupements angeloyle en combinaison avec d'autres agents dans le traitement du cancer Download PDFInfo
- Publication number
- CA2629337A1 CA2629337A1 CA002629337A CA2629337A CA2629337A1 CA 2629337 A1 CA2629337 A1 CA 2629337A1 CA 002629337 A CA002629337 A CA 002629337A CA 2629337 A CA2629337 A CA 2629337A CA 2629337 A1 CA2629337 A1 CA 2629337A1
- Authority
- CA
- Canada
- Prior art keywords
- cancer
- cell
- agent
- cells
- euphorbia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2005906295 | 2005-11-14 | ||
| AU2005906295A AU2005906295A0 (en) | 2005-11-14 | Therapeutic formulations | |
| PCT/AU2006/001700 WO2007053912A1 (fr) | 2005-11-14 | 2006-11-14 | Emploi d'ingenanes substitues par angeloyle en combinaison avec d'autres agents dans le traitement du cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2629337A1 true CA2629337A1 (fr) | 2007-05-18 |
Family
ID=38022911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002629337A Abandoned CA2629337A1 (fr) | 2005-11-14 | 2006-11-14 | Emploi d'ingenanes substitues par des groupements angeloyle en combinaison avec d'autres agents dans le traitement du cancer |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1951221A1 (fr) |
| JP (1) | JP2009516651A (fr) |
| KR (1) | KR20080080539A (fr) |
| CA (1) | CA2629337A1 (fr) |
| WO (1) | WO2007053912A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ801700A0 (en) | 2000-06-07 | 2000-06-29 | Peplin Research Pty Ltd | Enzyme and viral activation |
| CA2589992C (fr) * | 2004-12-13 | 2014-04-22 | Peplin Research Pty Ltd | Traitement de cancers solides |
| GB0525680D0 (en) | 2005-12-16 | 2006-01-25 | Peplin Ltd | Therapeutic compositions |
| US9895334B2 (en) * | 2007-04-30 | 2018-02-20 | Leo Laboratories Limited | Treatment of virally induced lesions |
| WO2011128780A1 (fr) | 2010-04-16 | 2011-10-20 | Leo Pharma A/S | Mébutate d'ingénol sous forme cristalline |
| US9388124B2 (en) | 2010-12-22 | 2016-07-12 | Leo Laboratories Limited | Ingenol-3-acylates I |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ801700A0 (en) * | 2000-06-07 | 2000-06-29 | Peplin Research Pty Ltd | Enzyme and viral activation |
| AUPQ923100A0 (en) * | 2000-08-07 | 2000-08-31 | Peplin Research Pty Ltd | Treatment of prostate cancer |
| CA2589992C (fr) * | 2004-12-13 | 2014-04-22 | Peplin Research Pty Ltd | Traitement de cancers solides |
-
2006
- 2006-11-14 EP EP06804519A patent/EP1951221A1/fr not_active Withdrawn
- 2006-11-14 KR KR1020087014304A patent/KR20080080539A/ko not_active Withdrawn
- 2006-11-14 CA CA002629337A patent/CA2629337A1/fr not_active Abandoned
- 2006-11-14 JP JP2008539193A patent/JP2009516651A/ja active Pending
- 2006-11-14 WO PCT/AU2006/001700 patent/WO2007053912A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009516651A (ja) | 2009-04-23 |
| EP1951221A1 (fr) | 2008-08-06 |
| WO2007053912A1 (fr) | 2007-05-18 |
| KR20080080539A (ko) | 2008-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102102640B1 (ko) | 뇌졸중 치료용 포르볼 에스테르들의 조성물 | |
| Anthoni et al. | Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis | |
| Salmon et al. | B-cell neoplasia in man | |
| Ho et al. | Chinese herbs as immunomodulators and potential disease-modifying antirheumatic drugs in autoimmune disorders | |
| Lai et al. | Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injury | |
| Chunxia et al. | Extracts of Arisaema rhizomatum CEC Fischer attenuate inflammatory response on collagen-induced arthritis in BALB/c mice | |
| WO2018183089A1 (fr) | Compositions pour le traitement et/ou la prévention du cancer | |
| KR20180095586A (ko) | 난소암 치료를 위한 hdac 억제제와 항-pd-l1 항체의 조합 | |
| CN104349787A (zh) | 含有荔枝草提取物或其馏分作为活性成分的预防或治疗stat-3介导疾病的药物组合物 | |
| US20240148740A1 (en) | Combination of an ahr inhibitor with a pdx inhibitor or doxorubicine | |
| CA2629337A1 (fr) | Emploi d'ingenanes substitues par des groupements angeloyle en combinaison avec d'autres agents dans le traitement du cancer | |
| Zakaria et al. | Antinociceptive, anti-inflammatory and antipyretic effects of Solanum nigrum aqueous extract in animal models. | |
| WO2018072743A1 (fr) | Utilisation d'un anticorps anti-pd-1 conjugué à un inhibiteur de l'ido dans la préparation d'un médicament antitumoral | |
| Ilhan et al. | Promising activity of Anthemis austriaca Jacq. on the endometriosis rat model and isolation of its active constituents | |
| WO2008109076A1 (fr) | Procédés d'amélioration de l'efficacité d'agents vasculotoxiques | |
| BR112020023816A2 (pt) | composição para prevenção ou tratamento de doença alérgica incluindo composto de inotodiol como ingrediente ativo | |
| Dong et al. | Salvianolic acid B ameliorates CNS autoimmunity by suppressing Th1 responses | |
| KR20230042034A (ko) | 비만을 치료하기 위한 조성물 | |
| RU2423139C2 (ru) | КОМПОЗИЦИИ, СОДЕРЖАЩИЕ Actinidia, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| AU2006313017A1 (en) | Use of angeloyl-substituted ingenanes in combination with other agents to treat cancer | |
| Gupta et al. | Immunorestorative and anti-inflammatory activity of leaf aqueous extract of Calotropis gigantean using flow cytometry | |
| CN113226304B (zh) | 免疫抑制药物组合物及其应用 | |
| KR102283258B1 (ko) | 진세노사이드의 사이클로스포린에 의한 면역 반응 개선 용도 | |
| KR20210137969A (ko) | 커큐민 및 다가 불포화 지방산을 유효성분으로 함유하는 관절염의 예방 및 치료용 조성물 | |
| ES2426174T3 (es) | Composición herbácea para trastornos inflamatorios |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |